---
title: "BAGARAZZI MARK — Ownership Dossier"
canonical: https://whiteintel.dev/entity/2fcf0d3e-56f0-5eab-92ea-555283630d8a
json: https://whiteintel.dev/api/public/dossier/2fcf0d3e-56f0-5eab-92ea-555283630d8a
identifier: sec:0001539067
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# BAGARAZZI MARK

**Type:** Company  
**Jurisdiction:** [US](https://whiteintel.dev/jurisdictions/us)  
**Identifier:** `sec:0001539067`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/2fcf0d3e-56f0-5eab-92ea-555283630d8a  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/2fcf0d3e-56f0-5eab-92ea-555283630d8a  

## Ownership & control

### Holdings / subsidiaries

- **INOVIO PHARMACEUTICALS, INC.** (officer) — https://whiteintel.dev/entity/7bd09d3e-0a05-5c96-a2bd-2959936bab96

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **BAGARAZZI MARK**. Human view: https://whiteintel.dev/entity/2fcf0d3e-56f0-5eab-92ea-555283630d8a · Structured JSON: https://whiteintel.dev/api/public/dossier/2fcf0d3e-56f0-5eab-92ea-555283630d8a._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._